Patient preference and decision-making for initiating metastatic colorectal cancer medical treatment

@article{Fu2015PatientPA,
  title={Patient preference and decision-making for initiating metastatic colorectal cancer medical treatment},
  author={Alex Zhenghong Fu and Kristi D. Graves and Roxanne E. Jensen and John Marshall and Margaret Formoso and Arnold L. Potosky},
  journal={Journal of Cancer Research and Clinical Oncology},
  year={2015},
  volume={142},
  pages={699-706}
}
Some medical treatment for metastatic colorectal cancer (CRC) may have marginal survival benefit, but cause toxicities. The purpose of this study is to determine metastatic CRC patients’ tradeoffs in making a decision to undergo new medical treatment. We conducted a survey of patients with a diagnosis of advanced CRC who were currently receiving or completed one chemotherapy regimen. First, patients were asked to rate the importance of 15 medical treatment-related adverse events that may arise… CONTINUE READING
2 Citations
38 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Quality of cancer care, plenary address. Washington, DC, world congress of psycho-oncology, from national to global: implementing the standard of psychosocial care in oncology

  • P Ganz
  • 2015
Highly Influential
3 Excerpts

Similar Papers

Loading similar papers…